Regenerex Pharma (RGPX) Amortizatization of Intangibles (2013 - 2025)

Regenerex Pharma (RGPX) has 7 years of Amortizatization of Intangibles data on file, last reported at -$3349.0 in Q1 2025.

• Amortizatization of Intangibles for Q1 2025 came in at -$3349.0, down 126.86% year-over-year; the trailing twelve-month figure through Mar 2025 was $19807.0 (down 63.13% YoY), and the FY2025 annual result was $19807.0, down 63.13% from the prior year.
• Amortizatization of Intangibles steadied at -$3349.0 in Q1 2025 per RGPX's latest filing, from -$3348.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $29052.0 in Q2 2024 and troughed at -$3349.0 in Q1 2025.
• A 3-year average of $9190.8 and a median of $6424.5 in 2023 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles soared 7545.26% in 2024, then slumped 126.86% in 2025.
• A 3-year view of Amortizatization of Intangibles shows it stood at $18370.0 in 2023, then sank by 118.23% to -$3348.0 in 2024, then dropped by 0.03% to -$3349.0 in 2025.
• Business Quant data shows RGPX's Amortizatization of Intangibles at -$3349.0 in Q1 2025, -$3348.0 in Q4 2024, and -$2548.0 in Q3 2024.